Stochastic modelling of the effects of human-mobility restriction and viral infection characteristics on the spread of COVID-19
After several months of "lockdown" as the sole answer to the COVID-19 pandemic, balancing the re-opening of society against the implementation of non-pharmaceutical measures needed for minimizing interpersonal contacts has become important. Here, we present a stochastic model that examines...
Saved in:
Published in | Scientific reports Vol. 11; no. 1; pp. 6856 - 10 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
25.03.2021
Nature Publishing Group Nature Portfolio |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | After several months of "lockdown" as the sole answer to the COVID-19 pandemic, balancing the re-opening of society against the implementation of non-pharmaceutical measures needed for minimizing interpersonal contacts has become important. Here, we present a stochastic model that examines this problem. In our model, people are allowed to move between discrete positions on a one-dimensional grid with viral infection possible when two people are collocated at the same site. Our model features three sets of adjustable parameters, which characterize (i) viral transmission, (ii) viral detection, and (iii) degree of personal mobility, and as such, it is able to provide a qualitative assessment of the potential for second-wave infection outbreaks based on the timing, extent, and pattern of the lockdown relaxation strategies. Our results suggest that a full lockdown will yield the lowest number of infections (as anticipated) but we also found that when personal mobility exceeded a critical level, infections increased, quickly reaching a plateau that depended solely on the population density. Confinement was not effective if not accompanied by a detection/quarantine capacity surpassing 40% of the symptomatic patients. Finally, taking action to ensure a viral transmission probability of less than 0.4, which, in real life, may mean actions such as social distancing or mask-wearing, could be as effective as a soft lockdown. |
---|---|
AbstractList | After several months of "lockdown" as the sole answer to the COVID-19 pandemic, balancing the re-opening of society against the implementation of non-pharmaceutical measures needed for minimizing interpersonal contacts has become important. Here, we present a stochastic model that examines this problem. In our model, people are allowed to move between discrete positions on a one-dimensional grid with viral infection possible when two people are collocated at the same site. Our model features three sets of adjustable parameters, which characterize (i) viral transmission, (ii) viral detection, and (iii) degree of personal mobility, and as such, it is able to provide a qualitative assessment of the potential for second-wave infection outbreaks based on the timing, extent, and pattern of the lockdown relaxation strategies. Our results suggest that a full lockdown will yield the lowest number of infections (as anticipated) but we also found that when personal mobility exceeded a critical level, infections increased, quickly reaching a plateau that depended solely on the population density. Confinement was not effective if not accompanied by a detection/quarantine capacity surpassing 40% of the symptomatic patients. Finally, taking action to ensure a viral transmission probability of less than 0.4, which, in real life, may mean actions such as social distancing or mask-wearing, could be as effective as a soft lockdown. After several months of "lockdown" as the sole answer to the COVID-19 pandemic, balancing the re-opening of society against the implementation of non-pharmaceutical measures needed for minimizing interpersonal contacts has become important. Here, we present a stochastic model that examines this problem. In our model, people are allowed to move between discrete positions on a one-dimensional grid with viral infection possible when two people are collocated at the same site. Our model features three sets of adjustable parameters, which characterize (i) viral transmission, (ii) viral detection, and (iii) degree of personal mobility, and as such, it is able to provide a qualitative assessment of the potential for second-wave infection outbreaks based on the timing, extent, and pattern of the lockdown relaxation strategies. Our results suggest that a full lockdown will yield the lowest number of infections (as anticipated) but we also found that when personal mobility exceeded a critical level, infections increased, quickly reaching a plateau that depended solely on the population density. Confinement was not effective if not accompanied by a detection/quarantine capacity surpassing 40% of the symptomatic patients. Finally, taking action to ensure a viral transmission probability of less than 0.4, which, in real life, may mean actions such as social distancing or mask-wearing, could be as effective as a soft lockdown.After several months of "lockdown" as the sole answer to the COVID-19 pandemic, balancing the re-opening of society against the implementation of non-pharmaceutical measures needed for minimizing interpersonal contacts has become important. Here, we present a stochastic model that examines this problem. In our model, people are allowed to move between discrete positions on a one-dimensional grid with viral infection possible when two people are collocated at the same site. Our model features three sets of adjustable parameters, which characterize (i) viral transmission, (ii) viral detection, and (iii) degree of personal mobility, and as such, it is able to provide a qualitative assessment of the potential for second-wave infection outbreaks based on the timing, extent, and pattern of the lockdown relaxation strategies. Our results suggest that a full lockdown will yield the lowest number of infections (as anticipated) but we also found that when personal mobility exceeded a critical level, infections increased, quickly reaching a plateau that depended solely on the population density. Confinement was not effective if not accompanied by a detection/quarantine capacity surpassing 40% of the symptomatic patients. Finally, taking action to ensure a viral transmission probability of less than 0.4, which, in real life, may mean actions such as social distancing or mask-wearing, could be as effective as a soft lockdown. Abstract After several months of "lockdown" as the sole answer to the COVID-19 pandemic, balancing the re-opening of society against the implementation of non-pharmaceutical measures needed for minimizing interpersonal contacts has become important. Here, we present a stochastic model that examines this problem. In our model, people are allowed to move between discrete positions on a one-dimensional grid with viral infection possible when two people are collocated at the same site. Our model features three sets of adjustable parameters, which characterize (i) viral transmission, (ii) viral detection, and (iii) degree of personal mobility, and as such, it is able to provide a qualitative assessment of the potential for second-wave infection outbreaks based on the timing, extent, and pattern of the lockdown relaxation strategies. Our results suggest that a full lockdown will yield the lowest number of infections (as anticipated) but we also found that when personal mobility exceeded a critical level, infections increased, quickly reaching a plateau that depended solely on the population density. Confinement was not effective if not accompanied by a detection/quarantine capacity surpassing 40% of the symptomatic patients. Finally, taking action to ensure a viral transmission probability of less than 0.4, which, in real life, may mean actions such as social distancing or mask-wearing, could be as effective as a soft lockdown. |
ArticleNumber | 6856 |
Author | Tsurui, Hiromichi Mizutani, Tetsuya Hall, Damien Ando, Shiho Matsuzawa, Yuki Kuroda, Yutaka |
Author_xml | – sequence: 1 givenname: Shiho surname: Ando fullname: Ando, Shiho organization: Department of Biotechnology and Life Sciences, Tokyo University of Agriculture and Technology – sequence: 2 givenname: Yuki surname: Matsuzawa fullname: Matsuzawa, Yuki organization: Department of Biotechnology and Life Sciences, Tokyo University of Agriculture and Technology – sequence: 3 givenname: Hiromichi surname: Tsurui fullname: Tsurui, Hiromichi organization: Department of Immunological Diagnosis, Juntendo University School of Medicine – sequence: 4 givenname: Tetsuya surname: Mizutani fullname: Mizutani, Tetsuya organization: Research and Education Center for Prevention of Global Infectious Diseases of Animals, Tokyo University of Agriculture and Technology – sequence: 5 givenname: Damien surname: Hall fullname: Hall, Damien organization: Department of Life Sciences and Applied Chemistry, Nagoya Institute of Technology, WPI Nano Life Science Institute, Kanazawa University, Department of Applied Physics, Alto University – sequence: 6 givenname: Yutaka surname: Kuroda fullname: Kuroda, Yutaka email: ykuroda@cc.tuat.ac.jp organization: Department of Biotechnology and Life Sciences, Tokyo University of Agriculture and Technology |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33767233$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kktv1DAUhSNUREvpH2CBIrFhE_AjduwNEpryGKlSFzy2luPHjEeJPdiZSl3x17mZaaHtYrLxI-d8uvf6vKxOYoquql5j9B4jKj6UFjMpGkRwIzgiXUOeVWcEtawhlJCTB_vT6qKUDYKPEdli-aI6pbTjHaH0rPrzfUpmrcsUTD0m64YhxFWdfD2tXe28d2Yq83G9G3VsxtSHIUy3dXZlysFMIcVaR1vfhKyHOsRZP98BMmszuRxmMhDiHli22Wk78xbXv5aXDZavqudeD8Vd3K3n1c8vn38svjVX11-Xi09XjeGYT41BhAtuhUWOEk1k38Gp1x5xbTlD1hIpTc9hT23vWa8Nwrpn0hhvNfOInlfLA9cmvVHbHEadb1XSQe0vUl4pnaHUwSkEbXPXIi-RaD1H2nTIG-eIIEJgY4H18cDa7vrRWePiBN0_gj7-E8NardKN6qRsOcUAeHcHyOn3DkapxlAMzF5Hl3ZFEYY4ES1iDKRvn0g3aZcjjEoRjlnXMsHkURWDZ2eUIAGqNw_r_lfwfRpAIA4Ck1Mp2XllwqTnB4U2wqAwUnP21CF7CrKn9tlTBKzkifWeftREDybIBcTO5f9lH3H9BWyu7P8 |
CitedBy_id | crossref_primary_10_1016_j_jfranklin_2022_03_035 crossref_primary_10_1007_s12551_023_01176_0 crossref_primary_10_1016_j_cplett_2022_139767 crossref_primary_10_3390_healthcare11050752 crossref_primary_10_1007_s11538_023_01152_5 crossref_primary_10_1146_annurev_publhealth_052220_093319 crossref_primary_10_1007_s12551_022_01033_6 crossref_primary_10_1108_EJMBE_07_2021_0215 |
Cites_doi | 10.1016/0301-4622(79)85012-7 10.1038/d41586-020-01003-6 10.1016/j.jinf.2020.04.024 10.1088/1478-3975/aba6d0 10.1093/oxfordjournals.epirev.a036121 10.1002/jmv.25750 10.3201/eid1211.060255 10.1038/s41577-020-0316-3 10.1038/s41586-020-2196-x 10.3201/eid1201.051370 10.1016/j.vaccine.2009.08.010 10.1016/S0140-6736(20)30211-7 10.1056/NEJMoa2001017 10.1007/978-0-387-33012-9_57 10.1098/rsif.2007.1197 10.1038/nature04795 10.1016/j.virol.2006.03.020 10.1096/fj.202001700RR 10.1183/13993003.01260-2020 10.1038/s41591-020-0869-5 10.1073/pnas.2004064117 10.1016/j.jinf.2020.06.073 10.12688/wellcomeopenres.15808.1 10.7554/eLife.57149 |
ContentType | Journal Article |
Copyright | The Author(s) 2021 The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2021 – notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU COVID DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM DOA |
DOI | 10.1038/s41598-021-86027-2 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Coronavirus Research Database ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection PML(ProQuest Medical Library) Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef Publicly Available Content Database MEDLINE - Academic Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2045-2322 |
EndPage | 10 |
ExternalDocumentID | oai_doaj_org_article_0eff6e40f9084f60ac70fcee282881cd PMC7994631 33767233 10_1038_s41598_021_86027_2 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Japan Society for the Promotion of Science grantid: KAKENHI-18H02385 funderid: http://dx.doi.org/10.13039/501100001691 – fundername: Japan Society for the Promotion of Science grantid: KAKENHI-18H02385 – fundername: ; grantid: KAKENHI-18H02385 |
GroupedDBID | 0R~ 3V. 4.4 53G 5VS 7X7 88A 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD ABDBF ABUWG ACGFS ACSMW ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M0L M1P M2P M48 M7P M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM SNYQT UKHRP AASML AAYXX AFPKN CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7XB 8FK AARCD COVID K9. PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c616t-c02686d8d0e32a29b786dbaf06ad650dd299cb6d653dbf5bac01ab59ccfda5f03 |
IEDL.DBID | M48 |
ISSN | 2045-2322 |
IngestDate | Wed Aug 27 01:09:40 EDT 2025 Thu Aug 21 14:08:18 EDT 2025 Fri Jul 11 03:39:51 EDT 2025 Wed Aug 13 08:04:39 EDT 2025 Wed Aug 13 09:18:14 EDT 2025 Thu Jan 02 22:36:58 EST 2025 Thu Apr 24 22:51:39 EDT 2025 Tue Jul 01 01:07:47 EDT 2025 Fri Feb 21 02:39:48 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c616t-c02686d8d0e32a29b786dbaf06ad650dd299cb6d653dbf5bac01ab59ccfda5f03 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41598-021-86027-2 |
PMID | 33767233 |
PQID | 2505253208 |
PQPubID | 2041939 |
PageCount | 10 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_0eff6e40f9084f60ac70fcee282881cd pubmedcentral_primary_oai_pubmedcentral_nih_gov_7994631 proquest_miscellaneous_2506284055 proquest_journals_2615745859 proquest_journals_2505253208 pubmed_primary_33767233 crossref_citationtrail_10_1038_s41598_021_86027_2 crossref_primary_10_1038_s41598_021_86027_2 springer_journals_10_1038_s41598_021_86027_2 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-03-25 |
PublicationDateYYYYMMDD | 2021-03-25 |
PublicationDate_xml | – month: 03 year: 2021 text: 2021-03-25 day: 25 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Scientific reports |
PublicationTitleAbbrev | Sci Rep |
PublicationTitleAlternate | Sci Rep |
PublicationYear | 2021 |
Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
References | Moghadas (CR9) 2020; 2 Fang, Nie, Penny (CR25) 2020; 92 Hardt (CR33) 1979; 10 Ishii (CR7) 2006; 351 Bell (CR19) 2006; 12 Gousseff (CR15) 2020; 81 Flaxman (CR10) 2020; 2 Ferguson (CR11) 2006; 442 Mizutani (CR6) 2006; 581 Bahl (CR5) 2020; 2 Muller (CR29) 2020; 17 Zhu (CR2) 2020; 382 Wölfel, Corman, Guggemos, Seilmaier, Zange, Müller, Niemeyer, Jones, Vollmar, Rothe, Hoelscher (CR31) 2020; 581 Tindale, Stockdale, Coombe, Garlock, Lau, Saraswat, Zhang, Chen, Wallinga, Colijn (CR32) 2020; 9 Moghadas (CR27) 2020; 117 Fine (CR17) 1993; 15 CR3 Glass (CR22) 2006; 12 CR8 Bell (CR18) 2006; 12 CR28 Imai (CR4) 2020; 5 CR26 Miller, Garcia Beltran, Bard, Gogakos, Anahtar, Astudillo, Yang, Thierauf, Fisch, Mahowald, Fitzpatrick (CR16) 2020; 34 He (CR30) 2020; 26 Chen (CR1) 2020; 395 Law, Leung, Xu (CR13) 2020; 26 Ferguson, Nicoll, Schwartz (CR20) 2009; 27 Caley, Philp, McCracken (CR21) 2008; 5 Adam (CR12) 2020; 580 Cheng (CR24) 2020; 81 Ota (CR14) 2020; 20 Esposito (CR23) 2020; 55 TE Miller (86027_CR16) 2020; 34 86027_CR8 X He (86027_CR30) 2020; 26 D Bell (86027_CR19) 2006; 12 Y Fang (86027_CR25) 2020; 92 M Gousseff (86027_CR15) 2020; 81 K Ishii (86027_CR7) 2006; 351 M Ota (86027_CR14) 2020; 20 T Mizutani (86027_CR6) 2006; 581 D Adam (86027_CR12) 2020; 580 N Zhu (86027_CR2) 2020; 382 86027_CR28 86027_CR26 PE Fine (86027_CR17) 1993; 15 NM Ferguson (86027_CR11) 2006; 442 SM Moghadas (86027_CR27) 2020; 117 SL Hardt (86027_CR33) 1979; 10 S Flaxman (86027_CR10) 2020; 2 M Muller (86027_CR29) 2020; 17 SM Moghadas (86027_CR9) 2020; 2 P Bahl (86027_CR5) 2020; 2 N Imai (86027_CR4) 2020; 5 LC Tindale (86027_CR32) 2020; 9 P Caley (86027_CR21) 2008; 5 N Chen (86027_CR1) 2020; 395 86027_CR3 D Bell (86027_CR18) 2006; 12 VC Cheng (86027_CR24) 2020; 81 R Wölfel (86027_CR31) 2020; 581 S Esposito (86027_CR23) 2020; 55 N Ferguson (86027_CR20) 2009; 27 RJ Glass (86027_CR22) 2006; 12 SK Law (86027_CR13) 2020; 26 |
References_xml | – volume: 10 start-page: 239 issue: 3–4 year: 1979 end-page: 243 ident: CR33 article-title: Rates of diffusion controlled reactions in one, two and three dimensions publication-title: Biophys. Chem. doi: 10.1016/0301-4622(79)85012-7 – volume: 2 start-page: 2 year: 2020 ident: CR10 article-title: Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe publication-title: Nature – volume: 580 start-page: 316 issue: 7803 year: 2020 end-page: 318 ident: CR12 article-title: Special report: The simulations driving the world's response to COVID-19 publication-title: Nature doi: 10.1038/d41586-020-01003-6 – volume: 81 start-page: 107 issue: 1 year: 2020 end-page: 114 ident: CR24 article-title: The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2 publication-title: J. Infect. doi: 10.1016/j.jinf.2020.04.024 – volume: 17 start-page: 065007 year: 2020 ident: CR29 article-title: Testing of asymptomatic individuals for fast feedback-control of COVID-19 pandemics publication-title: Phys. Biol. doi: 10.1088/1478-3975/aba6d0 – volume: 15 start-page: 265 issue: 2 year: 1993 end-page: 302 ident: CR17 article-title: Herd immunity: History, theory, practice publication-title: Epidemiol. Rev. doi: 10.1093/oxfordjournals.epirev.a036121 – volume: 92 start-page: 645 issue: 6 year: 2020 end-page: 659 ident: CR25 article-title: Transmission dynamics of the COVID-19 outbreak and effectiveness of government interventions: A data-driven analysis publication-title: J. Med. Virol. doi: 10.1002/jmv.25750 – volume: 12 start-page: 1671 issue: 11 year: 2006 end-page: 1681 ident: CR22 article-title: Targeted social distancing design for pandemic influenza publication-title: Emerg. Infect. Dis. doi: 10.3201/eid1211.060255 – ident: CR8 – volume: 20 start-page: 351 issue: 6 year: 2020 ident: CR14 article-title: Will we see protection or reinfection in COVID-19? publication-title: Nat. Rev. Immunol. doi: 10.1038/s41577-020-0316-3 – volume: 581 start-page: 465 issue: 7809 year: 2020 end-page: 469 ident: CR31 article-title: Virological assessment of hospitalized patients with COVID-2019 publication-title: Nature doi: 10.1038/s41586-020-2196-x – volume: 12 start-page: 88 issue: 1 year: 2006 end-page: 94 ident: CR18 article-title: Non-pharmaceutical interventions for pandemic influenza, national and community measures publication-title: Emerg. Infect. Dis. – volume: 12 start-page: 81 issue: 1 year: 2006 end-page: 87 ident: CR19 article-title: Non-pharmaceutical interventions for pandemic influenza, international measures publication-title: Emerg. Infect. Dis. doi: 10.3201/eid1201.051370 – volume: 27 start-page: 6383 issue: 45 year: 2009 end-page: 6386 ident: CR20 article-title: SIP 5: Social distancing during a pandemic. Not sexy, but sometimes effective: Social distancing and non-pharmaceutical interventions publication-title: Vaccine doi: 10.1016/j.vaccine.2009.08.010 – volume: 395 start-page: 507 issue: 10223 year: 2020 end-page: 513 ident: CR1 article-title: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study publication-title: Lancet doi: 10.1016/S0140-6736(20)30211-7 – volume: 382 start-page: 727 issue: 8 year: 2020 end-page: 733 ident: CR2 article-title: A novel coronavirus from patients with pneumonia in China, 2019 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2001017 – volume: 581 start-page: 323 year: 2006 end-page: 326 ident: CR6 article-title: Characterization of persistent SARS-CoV infection in Vero E6 cells publication-title: Adv. Exp. Med. Biol. doi: 10.1007/978-0-387-33012-9_57 – volume: 5 start-page: 631 issue: 23 year: 2008 end-page: 639 ident: CR21 article-title: Quantifying social distancing arising from pandemic influenza publication-title: J. R. Soc. Interface doi: 10.1098/rsif.2007.1197 – volume: 442 start-page: 448 issue: 7101 year: 2006 end-page: 452 ident: CR11 article-title: Strategies for mitigating an influenza pandemic publication-title: Nature doi: 10.1038/nature04795 – volume: 351 start-page: 368 issue: 2 year: 2006 end-page: 380 ident: CR7 article-title: Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs publication-title: Virology doi: 10.1016/j.virol.2006.03.020 – volume: 34 start-page: 13877 issue: 10 year: 2020 end-page: 13884 ident: CR16 article-title: Clinical sensitivity and interpretation of PCR and serological COVID-19 diagnostics for patients presenting to the hospital publication-title: FASEB J. doi: 10.1096/fj.202001700RR – ident: CR3 – volume: 55 start-page: 6 year: 2020 ident: CR23 article-title: Universal use of face masks for success against COVID-19: Evidence and implications for prevention policies publication-title: Eur. Respir. J. doi: 10.1183/13993003.01260-2020 – volume: 26 start-page: 672 issue: 5 year: 2020 end-page: 675 ident: CR30 article-title: Temporal dynamics in viral shedding and transmissibility of COVID-19 publication-title: Nat. Med. doi: 10.1038/s41591-020-0869-5 – volume: 2 start-page: 2 year: 2020 ident: CR5 article-title: Airborne or droplet precautions for health workers treating COVID-19? publication-title: J. Infect. Dis. – volume: 117 start-page: 9122 issue: 16 year: 2020 end-page: 9126 ident: CR27 article-title: Projecting hospital utilization during the COVID-19 outbreaks in the United States publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.2004064117 – volume: 81 start-page: 816 issue: 5 year: 2020 end-page: 846 ident: CR15 article-title: Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound? publication-title: J. Infect. doi: 10.1016/j.jinf.2020.06.073 – volume: 5 start-page: 59 year: 2020 ident: CR4 article-title: Adoption and impact of non-pharmaceutical interventions for COVID-19 publication-title: Wellcome Open Res. doi: 10.12688/wellcomeopenres.15808.1 – volume: 26 start-page: 264 issue: 3 year: 2020 end-page: 265 ident: CR13 article-title: Is reinfection possible after recovery from COVID-19? publication-title: Hong Kong Med. J. – volume: 9 start-page: e57149 year: 2020 ident: CR32 article-title: Evidence for transmission of COVID-19 prior to symptom onset publication-title: Elife doi: 10.7554/eLife.57149 – ident: CR28 – ident: CR26 – volume: 2 start-page: 2 year: 2020 ident: CR9 article-title: The implications of silent transmission for the control of COVID-19 outbreaks publication-title: Proc. Natl. Acad. Sci. U.S.A. – volume: 55 start-page: 6 year: 2020 ident: 86027_CR23 publication-title: Eur. Respir. J. doi: 10.1183/13993003.01260-2020 – volume: 10 start-page: 239 issue: 3–4 year: 1979 ident: 86027_CR33 publication-title: Biophys. Chem. doi: 10.1016/0301-4622(79)85012-7 – volume: 395 start-page: 507 issue: 10223 year: 2020 ident: 86027_CR1 publication-title: Lancet doi: 10.1016/S0140-6736(20)30211-7 – volume: 20 start-page: 351 issue: 6 year: 2020 ident: 86027_CR14 publication-title: Nat. Rev. Immunol. doi: 10.1038/s41577-020-0316-3 – volume: 581 start-page: 465 issue: 7809 year: 2020 ident: 86027_CR31 publication-title: Nature doi: 10.1038/s41586-020-2196-x – volume: 27 start-page: 6383 issue: 45 year: 2009 ident: 86027_CR20 publication-title: Vaccine doi: 10.1016/j.vaccine.2009.08.010 – volume: 17 start-page: 065007 year: 2020 ident: 86027_CR29 publication-title: Phys. Biol. doi: 10.1088/1478-3975/aba6d0 – volume: 2 start-page: 2 year: 2020 ident: 86027_CR5 publication-title: J. Infect. Dis. – volume: 117 start-page: 9122 issue: 16 year: 2020 ident: 86027_CR27 publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.2004064117 – volume: 382 start-page: 727 issue: 8 year: 2020 ident: 86027_CR2 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa2001017 – volume: 12 start-page: 81 issue: 1 year: 2006 ident: 86027_CR19 publication-title: Emerg. Infect. Dis. doi: 10.3201/eid1201.051370 – volume: 26 start-page: 672 issue: 5 year: 2020 ident: 86027_CR30 publication-title: Nat. Med. doi: 10.1038/s41591-020-0869-5 – volume: 81 start-page: 107 issue: 1 year: 2020 ident: 86027_CR24 publication-title: J. Infect. doi: 10.1016/j.jinf.2020.04.024 – ident: 86027_CR28 – volume: 12 start-page: 1671 issue: 11 year: 2006 ident: 86027_CR22 publication-title: Emerg. Infect. Dis. doi: 10.3201/eid1211.060255 – ident: 86027_CR26 – ident: 86027_CR3 – volume: 81 start-page: 816 issue: 5 year: 2020 ident: 86027_CR15 publication-title: J. Infect. doi: 10.1016/j.jinf.2020.06.073 – volume: 5 start-page: 631 issue: 23 year: 2008 ident: 86027_CR21 publication-title: J. R. Soc. Interface doi: 10.1098/rsif.2007.1197 – volume: 34 start-page: 13877 issue: 10 year: 2020 ident: 86027_CR16 publication-title: FASEB J. doi: 10.1096/fj.202001700RR – volume: 2 start-page: 2 year: 2020 ident: 86027_CR9 publication-title: Proc. Natl. Acad. Sci. U.S.A. – volume: 2 start-page: 2 year: 2020 ident: 86027_CR10 publication-title: Nature – volume: 12 start-page: 88 issue: 1 year: 2006 ident: 86027_CR18 publication-title: Emerg. Infect. Dis. – volume: 351 start-page: 368 issue: 2 year: 2006 ident: 86027_CR7 publication-title: Virology doi: 10.1016/j.virol.2006.03.020 – volume: 26 start-page: 264 issue: 3 year: 2020 ident: 86027_CR13 publication-title: Hong Kong Med. J. – volume: 442 start-page: 448 issue: 7101 year: 2006 ident: 86027_CR11 publication-title: Nature doi: 10.1038/nature04795 – volume: 9 start-page: e57149 year: 2020 ident: 86027_CR32 publication-title: Elife doi: 10.7554/eLife.57149 – ident: 86027_CR8 – volume: 92 start-page: 645 issue: 6 year: 2020 ident: 86027_CR25 publication-title: J. Med. Virol. doi: 10.1002/jmv.25750 – volume: 5 start-page: 59 year: 2020 ident: 86027_CR4 publication-title: Wellcome Open Res. doi: 10.12688/wellcomeopenres.15808.1 – volume: 15 start-page: 265 issue: 2 year: 1993 ident: 86027_CR17 publication-title: Epidemiol. Rev. doi: 10.1093/oxfordjournals.epirev.a036121 – volume: 581 start-page: 323 year: 2006 ident: 86027_CR6 publication-title: Adv. Exp. Med. Biol. doi: 10.1007/978-0-387-33012-9_57 – volume: 580 start-page: 316 issue: 7803 year: 2020 ident: 86027_CR12 publication-title: Nature doi: 10.1038/d41586-020-01003-6 |
SSID | ssj0000529419 |
Score | 2.3974059 |
Snippet | After several months of "lockdown" as the sole answer to the COVID-19 pandemic, balancing the re-opening of society against the implementation of... Abstract After several months of "lockdown" as the sole answer to the COVID-19 pandemic, balancing the re-opening of society against the implementation of... |
SourceID | doaj pubmedcentral proquest pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 6856 |
SubjectTerms | 631/114 631/114/2397 Coronaviruses COVID-19 COVID-19 - epidemiology COVID-19 - prevention & control COVID-19 - transmission COVID-19 - virology Disease Outbreaks - prevention & control Disease transmission Humanities and Social Sciences Humans Infections Mobility Models, Statistical Movement multidisciplinary Pandemics Population density Quarantine SARS-CoV-2 - isolation & purification Science Science (multidisciplinary) Stochastic models Stochastic Processes Viral infections |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Jb9UwELZQpUpcEDuBUhmJG1j1Fsc-QhcVJOAARb1Zjh2rldoEta-HnvrXO-PkPRoocOEWx7HlZcYzjsffR8hrsBnWRhmZAGee6WANsyoH_JEfQLfQ6uKJ7qfPZv9AfzysD29QfWFM2AgPPA7cFu9yNp3m2XGrs-EhNjzDyo5bBStiwtUXbN6NzdSI6i2dFm66JcOV3ToHS4W3yaRgSLvUMDmzRAWw_zYv8_dgyV9OTIsh2rtP7k0eJH03tvwBudP1D8n6yCl5-YhcfV0M8Sgg_DItNDd435wOmYKnR6foDUwWcj52OpTg2EuKFB1nx-WSAw19ohj7e0KXoVo9jXNgZwqvsEJoJAgJ1rf95fuHHSbcY3Kwt_tte59NLAssGmEWLMIuzJpkE--UDNK1DaTakLkJCdy3lMBgxdbAs0ptrtsQuQht7WLMKdSZqydkrR_67hmBTohkecxdrmFh6LRtYzbJOdlqBUVkRcRyxH2cIMiRCePEl6NwZf04Sx5myZdZ8lDmzarMjxGA469fv8eJXH2J4NnlBYiUn0TK_0ukKrKxFAM_afS5l4XxT0lub88Gz7DRsPdyFXm1ygZVxfOX0HfDRanCgDfA67oiT0ehWjVUIaqOVKoizUzcZj2Z5_THRwUOvHFOGyUq8nYpmD-b9eeRev4_RuoFuStRo7hist4ga4uzi-4lOGmLdrPo4zVFMDly priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Nb9UwDI9gCIkL4pvCQEHiBtHSpE2TE4LBNJCAAwy9W5QmzTZptOO9t8NO_OvYaV6nwtitbZooie3YiR3_CHkJOkNrLzwrwZhnldOKaRkdHuQ7kC3UuujR_fxF7R9Unxb1Ih-4rXJY5WZNTAt1GDyeke-IhLgmBddvTn8xRI1C72qG0LhObmDqMuTqZtFMZyzoxapKk-_KcKl3VqCv8E6ZKBmCLzVMzPRRStt_ma35b8jkX37TpI727pDb2Y6kb0fC3yXXuv4euTkiS57fJ7-_rQd_5DAJM01gN3jrnA6Rgr1HcwwHviaIPvZzSCGy5xSBOpbH6aoDdX2gGAF8QjcBWz318_TOFD5hg9BJYBVsb_frj4_vWWkekIO9D99391nGWmBelWrNPOzFtAo68E4KJ0zbwFvrIlcugBEXAqgt3yp4lqGNdes8L11bG-9jcHXk8iHZ6oe-e0xgEGXQ3Mcu1rA8dJVufVTBGNFWEqqIgpSbGbc-JyJHPIwTmxziUtuRShaoZBOVLNR5NdU5HdNwXPn3OyTk9Cem0E4fhuWhzRJpOUy26ioeDddVVNz5hkcwGXAPqksfCrK9YQOb5XplL7jw8mKwD5sKdmCmIC-mYhBY9MK4vhvOUhMKbAJe1wV5NDLV1FGJuXWElAVpZuw2G8m8pD8-SknBG2MqJcuCvN4w5kW3_j9TT64e5FNyS6CscMlEvU221suz7hkYYev2eZK0P9L4L_w priority: 102 providerName: ProQuest – databaseName: HAS SpringerNature Open Access 2022 dbid: AAJSJ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELaqVkhcEG8CBRmJG1j4kTj2cSlUZSXgUIp6sxw7ppVKgrbbQ0_8dWacZFFgQeIWxw_5MeOZZGa-IeQFyAxjggxMgDLPSm80Myp5_JHvgbdQ6qJF98NHfXRSLk-r0x0ip1iY7LSfIS3zNT15h72-BEGDwWBSMMyaVDO4dvcQqh1oe2-xWB4vN39W0HZVCjtGyHBltnSeSaEM1r9Nw_zTUfI3a2kWQoe3ya1Re6SLYb53yE7b3SU3hnyS1_fIj-N1H848Qi_TnOIGY81pnyhoeXT03MBiTszHvvXZMfaaYnqO1XkOcKC-ixT9fi_o5KbV0TAHdabwCgeESQKB4HgHn768f8uEvU9ODt99PjhiY4YFFrTQaxbgC8zoaCJvlfTSNjWUGp-49hFUtxhBWIVGw7OKTaoaH7jwTWVDSNFXiasHZLfru_YRgUWIaHhIbargUmhL04Sko7WyKRV0kQUR0467MMKPYxaMC5fN4Mq44ZQcnJLLp-Sgz8tNn-8D-MY_W7_Bg9y0RODs_KJffXUjITkOm63bkifLTZk096HmCRQF_PI0IsSC7E9k4EZuvnQyZ_tTkpvt1aAVAiWayhbk-aYa2BRtL75r-6s8hAZNgFdVQR4ORLWZqEJEHalUQeoZuc1WMq_pzs8yFHhtbamVKMiriTB_TevvO_X4_5o_ITcl8g5XTFb7ZHe9umqfgiq2bp6NvPcTEzQvOQ priority: 102 providerName: Springer Nature |
Title | Stochastic modelling of the effects of human-mobility restriction and viral infection characteristics on the spread of COVID-19 |
URI | https://link.springer.com/article/10.1038/s41598-021-86027-2 https://www.ncbi.nlm.nih.gov/pubmed/33767233 https://www.proquest.com/docview/2505253208 https://www.proquest.com/docview/2615745859 https://www.proquest.com/docview/2506284055 https://pubmed.ncbi.nlm.nih.gov/PMC7994631 https://doaj.org/article/0eff6e40f9084f60ac70fcee282881cd |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fb9MwELbGJiReEL8XGJWReAODYyeO84BQVzaNShuIUdS3yLFjNqkkW9dJ9Il_nTsnKSoUxFMbO7Yc-y73Ob67j5DnYDO0tsKyGMA8S4xWTEtv8EO-Ad1Cq4snuscn6miSjKfpdIv0dEfdBF5t3Nohn9RkPnv1_XL5FhT-TRsyrl9fgRHCQDERM2RUyhi8knfAMmXIaHDcwf0217fIk8D1gUnYGYAJ0cXRbO5mzVaFlP6bcOif7pS_nakGU3V4h9zuMCYdtkJxl2xV9T1ys2WdXN4nP04XjT0zmKCZBiIcjEinjaeABWnn34GXgb6PfWuC--ySIonH_DyEQVBTO4rewTPaO3PV1K6nfqZQhB3CIEGMsL_Rhy_v37E4f0AmhwefR0es42FgVsVqwSzs07Ry2vFKCiPyMoOr0niujAOA5xyYNFsq-C9d6dPSWB6bMs2t9c6knsuHZLtu6mqXwEPETnPrK5_Cq6NKdGm9cnkuykRCExGRuJ_xwnZJypErY1aEw3Kpi3aVClilIqxSAW1erNpctCk6_nn3Pi7k6k5Mrx0KmvnXotPWgsNkqyrhPuc68Yobm3EPcAL3pzq2LiJ7vRgUvcgWInACSsH15mrAjlkCu7M8Is9W1aDMeEJj6qq5Dl0owAs8TSPyqBWq1UAl5t0RUkYkWxO3tSdZr6nPz0LC8CzPEyXjiLzsBfPXsP4-U4__Y5hPyC2BCsMlE-ke2V7Mr6ungNIW5YDcyKbZgOwMh-PTMfzuH5x8_ASlIzUahC8fg6CcPwGgIjzy |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKEYIL4k2ggJHgBFYdO3GcA0LQUu3SBwdatLfg2DGtVJKyuxXaE_-I38iM86gWSm-9JXFs2Z7xzNgzno-QF6AztLbCshiMeZYYrZiW3uBBvoG1hVoXPbq7e2p0kHycpJMV8ru_C4Nhlb1MDILaNRbPyNdFQFyTguu3Jz8Yokahd7WH0GjZYrta_IQt2-zNeBPo-1KIrQ_7GyPWoQowq2I1ZxZ2HVo57XglhRF5mcFbaTxXxoG54hwIaFsqeJau9GlpLI9NmebWemdSzyW0e4VcBcXLcbOXTbLhTAe9Zkmcd3dzuNTrM9CPeIdNxAzBnjImlvRfgAk4z7b9N0TzLz9tUH9bt8jNzm6l71pGu01WqvoOudYiWS7ukl-f5409NJj0mQZwHbzlThtPwb6kXcwIvgZIQPa9CSG5C4rAINOjcLWCmtpRjDg-pn2AWE3tcjppCp-wQegksCa2t_Hpy3iTxfk9cnApVLhPVuumrh4SGETsNLe-8imIoyrRpfXK5bkoEwlVRETifsYL2yU-R_yN4yI44KUuWioVQKUiUKmAOq-GOidt2o8L_36PhBz-xJTd4UMz_VZ0EqDgMNmqSrjPuU684sZm3IOJgnteHVsXkbWeDYpOjsyKM64_vxjs0SyBHV8ekedDMQgI9PqYumpOQxMKbBCephF50DLV0FGJuXyElBHJlthtaSTLJfXRYUhCnuV5omQckdc9Y5516_8z9ejiQT4j10f7uzvFznhv-zG5IXDdcMlEukZW59PT6gkYgPPyaVh1lHy97GX-B9Y4byE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKViAuiDeBAkaCE1jr2InjHBCi3a5aCksFtOotOHZMK5Wk7G6F9sT_4tcx4022Wii99ZbEsWV7Hh57xvMR8hzWDK2tsCwGY54lRiumpTd4kG9AtnDVRY_uh5Ha2kveHaQHK-R3dxcGwyo7nRgUtWssnpH3RUBck4Lrvm_DInYHwzcnPxgiSKGntYPTmLPITjX7Cdu3yevtAdD6hRDDzS8bW6xFGGBWxWrKLOxAtHLa8UoKI_Iyg7fSeK6MA9PFOVDWtlTwLF3p09JYHpsyza31zqSeS2j3ClnNcFfUI6vrm6PdT4sTHvShJXHe3tThUvcnsFrijTYRM4R-yphYWg0DaMB5lu6_AZt_eW3DYji8SW60Vix9O2e7W2Slqm-Tq3Ncy9kd8uvztLGHBlNA0wC1g3feaeMpWJu0jSDB1wAQyL43IUB3RhEmZHwULlpQUzuK8cfHtAsXq6ldTi5N4RM2CJ0ERsX2Nj7ubw9YnN8le5dCh3ukVzd19YDAIGKnufWVT0E5VYkurVcuz0WZSKgiIhJ3M17YNg06onEcF8EdL3Uxp1IBVCoClQqo83JR52SeBOTCv9eRkIs_MYF3-NCMvxWtPig4TLaqEu5zrhOvuLEZ92Cw4A5Yx9ZFZK1jg6LVKpPiTAbOLwbrNEtg_5dH5NmiGNQF-oBMXTWnoQkFFglP04jcnzPVoqMSM_sIKSOSLbHb0kiWS-qjw5CSPMvzRMk4Iq86xjzr1v9n6uHFg3xKroGIF--3RzuPyHWBYsMlE-ka6U3Hp9VjsAan5ZNW7Cj5etmS_gcYX3S8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Stochastic+modelling+of+the+effects+of+human-mobility+restriction+and+viral+infection+characteristics+on+the+spread+of+COVID-19&rft.jtitle=Scientific+reports&rft.au=Ando%2C+Shiho&rft.au=Matsuzawa%2C+Yuki&rft.au=Tsurui%2C+Hiromichi&rft.au=Mizutani%2C+Tetsuya&rft.date=2021-03-25&rft.issn=2045-2322&rft.eissn=2045-2322&rft.volume=11&rft.issue=1&rft.spage=6856&rft_id=info:doi/10.1038%2Fs41598-021-86027-2&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon |